// App-Quantinova.ai

P1691 : COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS

Researchers

Presenter

  • Marko Lucijanic

Principal Investigators

  • Ivana Jurin

  • Martina Sedinic

  • Anica Sabljic

  • Irzal Hadzibegovic

  • Tomo Lucijanic

  • Rajko Kusec

Medical Centers

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Cardiology

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

  • Hematology Department,University Hospital Dubrava,Zagreb,Croacia

Locations

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Pulmonary embolism

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT05151094

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved